Exosomes Market To Grow at CAGR 34%, Market Value to Reach USD 2,273 Million By 2030
The report analyzes and forecasts the Exosomes Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Exosomes Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Exosomes Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Exosomes Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2926
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
Some of the prominent players in global exosomesmarket are Thermo Fisher Scientific, Inc., Qiagen, Hitachi Chemical Diagnostics Inc., Fujifilm, Danaher, Illumina, Inc., Lonza, Takara Bio Company, MiltenyiBiotec, Malvern Instruments Ltd., System Biosciences Inc., and MBL International Corporation.
The major market segments of Exosomes Market are as below:
Market by Workflow
· Downstream Analysis
o Protein analysis using Blotting & ELISA
o Cell Surface Marker Analysis using Flow Cytometry
o Proteomic analysis using Mass Spectrometry
o RNA analysis with NGS & PCR
o Others
· Isolation Methods
o Ultracentrifugation
o Precipitation
o Immunocapture on Beads
o Filtration
Market by Biomolecule Type
· Non-coding RNAs
· Proteins /Peptides
· mRNA
· DNA Fragments
· Lipids
Market by Application
· Cancer
· Cardiovascular Diseases
· Neurodegenerative Diseases
· Infectious Diseases
· Others
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of Exosomes Market
1.1. Definition and Scope
1.1.1. Definition of Exosomes
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global ExosomesMarket
1.2. Summary
1.2.1. Executive Summary
1.2.2. Exosomes MarketByWorkflow
1.2.3. ExosomesMarketByBiomolecule Type
1.2.4. ExosomesMarketByApplication
1.2.5. ExosomesMarketBy Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Exosomes Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Exosomes Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2021
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of ExosomesMajor Manufacturers in 2021
CHAPTER 5. Exosomes Market By Workflow
5.1. Introduction
5.2. Exosomes Market Revenue ByWorkflow
5.2.1. Exosomes Market Revenue (US$ Mn) and Forecast, By Workflow, 2018-2030
5.2.2. Downstream Analysis
5.2.2.1. Downstream AnalysisMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.2.2. Protein Analysis Using Blotting & ELISA
5.2.2.2.1. Protein Analysis Using Blotting & ELISAMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.2.3. Cell Surface Marker Analysis using Flow Cytometry
5.2.2.3.1. Cell Surface Marker Analysis using Flow CytometryMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.2.4. Proteomic Analysis Using Mass Spectrometry
5.2.2.4.1. Proteomic Analysis Using Mass SpectrometryMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.2.5. RNA Analysis with NGS & PCR
5.2.2.5.1. RNA Analysis with NGS & PCRMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.2.6. Others
5.2.2.6.1. OthersMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.3. Isolation Methods
5.2.3.1. Isolation MethodsMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.3.2. Ultracentrifugation
5.2.3.2.1. UltracentrifugationMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.3.3. Precipitation
5.2.3.3.1. PrecipitationMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.3.4. Immunocapture on Beads
5.2.3.4.1. Immunocapture on BeadsMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.3.5. Filtration
5.2.3.5.1. FiltrationMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 6. Exosomes Market Revenue By Biomolecule Type
6.1. Introduction
6.2. Exosomes MarketRevenue (US$ Mn)By Biomolecule Type
6.2.1. ExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
6.2.2. Non-coding RNAs
6.2.2.1. Non-coding RNAsMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.3. Proteins /Peptides
6.2.3.1. Proteins /PeptidesMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.4. mRNA
6.2.4.1. mRNAMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.5. DNA fragments
6.2.5.1. DNA fragmentsMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.6. Lipids
6.2.6.1. LipidsMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 7. Exosomes Market Revenue By Application
7.1. Introduction
7.2. ExosomesMarket Revenue (US$ Mn) By Application
7.2.1. ExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
7.2.2. Cancer
7.2.2.1. CancerMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
7.2.3. Cardiovascular Diseases
7.2.3.1. Cardiovascular DiseasesMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
7.2.4. Neurodegenerative Diseases
7.2.4.1. Neurodegenerative DiseasesMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
7.2.5. Infectious Diseases
7.2.5.1. Infectious DiseasesMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
7.2.6. Others
7.2.6.1. OthersMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 8. North America Exosomes Market By Country
8.1. North America ExosomesMarket Overview
8.2. U.S.
8.2.1. U.S.ExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
8.2.2. U.S.ExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
8.2.3. U.S.ExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
8.3. Canada
8.3.1. Canada ExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
8.3.2. Canada ExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
8.3.3. Canada ExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
8.4. North America PEST Analysis
CHAPTER 9. Europe Exosomes Market By Country
9.1. Europe ExosomesMarket Overview
9.2. U.K.
9.2.1. U.K.ExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
9.2.2. U.K.ExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
9.2.3. U.K.ExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
9.3. Germany
9.3.1. GermanyExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
9.3.2. GermanyExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
9.3.3. GermanyExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
9.4. France
9.4.1. FranceExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
9.4.2. FranceExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
9.4.3. FranceExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
9.5. Spain
9.5.1. SpainExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
9.5.2. SpainExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
9.5.3. SpainExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
9.6. Rest of Europe
9.6.1. Rest of EuropeExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
9.6.2. Rest of EuropeExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
9.6.3. Rest of EuropeExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
9.7. Europe PEST Analysis
CHAPTER 10. Asia-Pacific Exosomes Market By Country
10.1. Asia-Pacific ExosomesMarket Overview
10.2. China
10.2.1. ChinaExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
10.2.2. ChinaExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
10.2.3. ChinaExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
10.3. Japan
10.3.1. JapanExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
10.3.2. JapanExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
10.3.3. JapanExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
10.4. India
10.4.1. IndiaExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
10.4.2. IndiaExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
10.4.3. IndiaExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
10.5. Australia
10.5.1. AustraliaExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
10.5.2. AustraliaExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
10.5.3. AustraliaExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
10.6. South Korea
10.6.1. South KoreaExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
10.6.2. South KoreaExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
10.6.3. South KoreaExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-PacificExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
10.7.2. Rest of Asia-PacificExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
10.7.3. Rest of Asia-PacificExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Exosomes Market By Country
11.1. Latin AmericaExosomesMarket Overview
11.2. Brazil
11.2.1. BrazilExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
11.2.2. BrazilExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
11.2.3. BrazilExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
11.3. Mexico
11.3.1. MexicoExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
11.3.2. MexicoExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
11.3.3. MexicoExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
11.4. Rest of Latin America
11.4.1. Rest of Latin AmericaExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
11.4.2. Rest of Latin AmericaExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
11.4.3. Rest of Latin AmericaExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Exosomes Market By Country
12.1. Middle East & Africa ExosomesMarket Overview
12.2. GCC
12.2.1. GCCExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
12.2.2. GCCExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
12.2.3. GCCExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
12.3. South Africa
12.3.1. South AfricaExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
12.3.2. South AfricaExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
12.3.3. South AfricaExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa ExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030
12.4.2. Rest of Middle East & Africa ExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030
12.4.3. Rest of Middle East & Africa ExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Exosomes Market
13.1. ExosomesMarket Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. Product Launches and ProductEnhancements
13.2.3. Mergers And Acquisition InGlobal ExosomesMarket
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Thermo Fisher Scientific, Inc.
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Market Revenue (US$ Mn), 2021
14.1.3.2. Thermo Fisher Scientific, Inc.2021Exosomes Business Regional Distribution
14.1.4. Product/service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Qiagen
14.3. Hitachi Chemical Diagnostics Inc.
14.4. Fujifilm
14.5. Danaher
14.6. Illumina, Inc.
14.7. Lonza
14.8. Takara Bio Company
14.9. MiltenyiBiotec
14.10. Malvern Instruments Ltd.
14.11. System Biosciences Inc.
14.12. MBL International Corporation
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2926
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
